LGI3 promotes the progression of TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB axis
- 23 August 2025
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 44 (39) , 3729-3740
Abstract
Transcription factor binding to IGHM enhancer 3-rearranged renal cell carcinoma (TFE3-RCC) is characterized by its aggressive nature, limited treatment options, and poor prognosis. However, the downstream targets of TFE3 fusion protein responsible for its tumorigenesis and progression remain unclear. Here, we demonstrated that leucine-rich repeat LGI family member 3 (LGI3) is a direct target of TFE3 fusion protein. TFE3 fusion protein can bind to the promoter of LGI3 and then activate its transcription. Importantly, LGI3 contributes to the proliferation, migration, and invasion of TFE3-RCC. Mechanistically, LGI3 interacts with gem nuclear organelle-associated protein 6 (GEMIN6) and inhibits its degradation via decreasing its ubiquitination. GEMIN6 upregulation promotes the mRNA maturation of Aurora B kinase (AURKB), thereby promoting the progression of TFE3-RCC. Importantly, drugs targeting GEMIN6 or AURKB significantly suppressed the growth of TFE3-RCC cells and organoids. In human TFE3-RCC tissues, LGI3 is highly expressed and positively correlated with GEMIN6 and AURKB. Overall, we revealed a novel mechanism underlying the progression of TFE3-RCC and provided potential new therapeutic targets.Keywords
This publication has 27 references indexed in Scilit:
- NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinomaThe Journal of Pathology, 2024
- Integrative clinical and molecular characterization of translocation renal cell carcinomaCell Reports, 2022
- TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinomaLaboratory Investigation, 2021
- Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyThe Lancet Oncology, 2019
- Renal cell carcinomaNature Reviews Disease Primers, 2017
- Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 TrialEuropean Urology, 2016
- Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersNature Reviews Urology, 2014
- Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Leucine-Rich Glioma Inactivated 3 Induces Neurite Outgrowth Through Akt and Focal Adhesion KinaseNeurochemical Research, 2010
- Differential expression of the LGI and SLIT families of genes in human cancer cellsGene, 2005